News and Announcements
NuSep Receives Final Tranche Payment Under 15% Share Placement
- Published January 02, 2013 12:32AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Sydney, Australia 2nd January 2013- The Board of NuSep (ASX:NSP) wishes to advise the market that it has received the third and final payment of $227,090.75 as per the terms of the 15% share placement announced to the market on 30 October 2012. Of the $1, 167, 090.75 placement previously announced, $940, 000 was receive in two prior tranches paid on 30 October 2012 and on 21 November 2012. Following receipt of this payment the Company has issued a further 4,672,725 shares at 7 cents per share. The issue of shares under the final tranche includes the issue of shares for the $100,000 deposit received on 30 October 2012 for which shares had not previously been issued.
Separately, NuSep ratified this 15% placement of shares to an investor at its AGM on 30 November 2012.
———-
To view the full article, please click the link below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
